Skip to content

Advertisement

Hepatitis and co-infections

Section edited by Jean-Claude Desenclos

This section aims to publish studies looking at all aspects of the prevention, diagnosis and management of hepatitis in humans as well as related molecular genetics, pathophysiology, and epidemiology

Page 1 of 8
  1. Content type: Research article

    Infants born to hepatitis B surface antigen (HBsAg) positive mothers are at a higher risk for Hepatitis B virus (HBV) infection. Host genetic background plays an important role in determining the strength of i...

    Authors: Meng Zhuo Cao, Yan Hua Wu, Si Min Wen, Yu Chen Pan, Chong Wang, Fei Kong, Chuan Wang, Jun Qi Niu, Jie Li and Jing Jiang

    Citation: BMC Infectious Diseases 2018 18:274

    Published on:

  2. Content type: Research article

    Female gender and favorable IFNL3 genotypes are the primary independent predictors of spontaneous clearance of HCV infection. However, chronic hepatitis C infection occurs in numerous women carrying favorable IFN...

    Authors: Zhe Xie, Yuantao Li, Lu Long, Hua Liang, Weiping Cai and Tao Shen

    Citation: BMC Infectious Diseases 2018 18:254

    Published on:

  3. Content type: Research article

    Spontaneous bacterial peritonitis (SBP) and bacterascites (BA) represent frequent and serious complications in cirrhosis patients with ascites. However, few detailed data are available regarding the clinical a...

    Authors: Nian-zhi Ning, Tao Li, Ju-ling Zhang, Fen Qu, Jie Huang, Xiong Liu, Zhan Li, Wei Geng, Jun-liang Fu, Wang Huan, Shu-yong Zhang, Chun-mei Bao and Hui Wang

    Citation: BMC Infectious Diseases 2018 18:253

    Published on:

  4. Content type: Research article

    HBsAg immune-escape mutations can favor HBV-transmission also in vaccinated individuals, promote immunosuppression-driven HBV-reactivation, and increase fitness of drug-resistant strains. Stop-codons can enhan...

    Authors: Luna Colagrossi, Lucas E. Hermans, Romina Salpini, Domenico Di Carlo, Suzan D. Pas, Marta Alvarez, Ziv Ben-Ari, Greet Boland, Bianca Bruzzone, Nicola Coppola, Carole Seguin-Devaux, Tomasz Dyda, Federico Garcia, Rolf Kaiser, Sukran Köse, Henrik Krarup…

    Citation: BMC Infectious Diseases 2018 18:251

    Published on:

  5. Content type: Research article

    Direct-acting anti-viral agents have improved the treatment of chronic hepatitis C virus (HCV) infection, but this treatment is challenging for patients using co-medications because of potential drug–drug inte...

    Authors: Daniel J. Ruzicka, Jumpei Tetsuka, Go Fujimoto and Tatsuya Kanto

    Citation: BMC Infectious Diseases 2018 18:237

    Published on:

  6. Content type: Research article

    Management of chronic hepatitis C (CHC) has significantly accelerated in the last few years. Currently, second generation direct acting antivirals (DAAs) promise clearance of infection in most of patients. Her...

    Authors: Simone Lanini, Paola Scognamiglio, Alessandra Mecozzi, Lorella Lombardozzi, Vincenzo Vullo, Mario Angelico, Antonio Gasbarrini, Gloria Taliani, Adolfo Francesco Attili, Carlo Federico Perno, Adriano De Santis, Vincenzo Puro, Fabio Cerqua, Gianpiero D’Offizi, Adriano Pellicelli, Orlando Armignacco…

    Citation: BMC Infectious Diseases 2018 18:223

    Published on:

  7. Content type: Research article

    Hepatitis C virus (HCV) is the most common blood-borne viral infection in the United States. Previously, we used data from the National Health and Nutrition Examination Survey (NHANES) and mortality data from ...

    Authors: Eric W. Hall, Eli S. Rosenberg and Patrick S. Sullivan

    Citation: BMC Infectious Diseases 2018 18:224

    Published on:

  8. Content type: Research article

    This study evaluated cause-specific mortality trends including liver-related mortality among people with a hepatitis B virus (HBV) and hepatitis C virus (HCV) notification in New South Wales, Australia.

    Authors: Maryam Alavi, Jason Grebely, Behzad Hajarizadeh, Janaki Amin, Sarah Larney, Matthew G. Law, Jacob George, Louisa Degenhardt and Gregory J. Dore

    Citation: BMC Infectious Diseases 2018 18:215

    Published on:

  9. Content type: Research article

    Co-infection with HIV negatively impacts the progression of chronic hepatitis B virus (HBV) infection, including causing rapid progression to liver fibrosis. Sub-Saharan Africa represents arguably the most imp...

    Authors: Tongai Gibson Maponga, Monique I. Andersson, Christoffel J. van Rensburg, Joop E. Arends, Jantjie Taljaard, Wolfgang Preiser and Richard H. Glashoff

    Citation: BMC Infectious Diseases 2018 18:214

    Published on:

  10. Content type: Research article

    A marked increase of hepatitis E cases has recently been observed in the Netherlands. Causes of the (re-)emergence of hepatitis E virus (HEV) and exact sources and routes of transmission of HEV infection are c...

    Authors: Sofie H. Mooij, Boris M. Hogema, Anna D. Tulen, Wilfrid van Pelt, Eelco Franz, Hans L. Zaaijer, Michel Molier and Agnetha Hofhuis

    Citation: BMC Infectious Diseases 2018 18:173

    Published on:

  11. Content type: Research article

    Efficient control of acute hepatitis B requires identification of current transmission routes. Countries in Central-Eastern Europe including Poland attribute an important fraction of cases to nosocomial transm...

    Authors: Małgorzata Stępień, Karolina Zakrzewska and Magdalena Rosińska

    Citation: BMC Infectious Diseases 2018 18:164

    Published on:

  12. Content type: Research article

    People who inject drugs (PWID) are most at risk of hepatitis C virus infection in Australia. The introduction of transient elastography (TE) (measuring hepatitis fibrosis) and direct acting antiviral medicatio...

    Authors: Stelliana Goutzamanis, Joseph S. Doyle, Alexander Thompson, Paul Dietze, Margaret Hellard and Peter Higgs

    Citation: BMC Infectious Diseases 2018 18:151

    Published on:

  13. Content type: Research article

    As the socioeconomic conditions in Jordan have improved over recent decades the disease and economic burden of Hepatitis A has increased. The purpose of this study is to assess the potential health and economi...

    Authors: Wail A. Hayajneh, Vincent J. Daniels, Cerise K. James, Muhammet Nabi Kanıbir, Matthew Pilsbury, Morgan Marks, Michelle G. Goveia, Elamin H. Elbasha, Erik Dasbach and Camilo J. Acosta

    Citation: BMC Infectious Diseases 2018 18:119

    Published on:

  14. Content type: Research article

    Characteristics of hepatitis B (HBV) and delta (HDV) coinfection in various geographical regions, including Israel, remain unclear. Here we studied HDV seroprevalence in Israel, assessed HDV/HBV viral loads, c...

    Authors: Rachel Shirazi, Daniela Ram, Aviya Rakovsky, Efrat Bucris, Yael Gozlan, Yaniv Lustig, Pninit Shaked-Mishan, Orit Picard, Yonat Shemer-Avni, Haim Ben-Zvi, Ora Halutz, Yoav Lurie, Ella Veizman, Matthias Carlebach, Marius Braun, Michal Cohen- Naftaly…

    Citation: BMC Infectious Diseases 2018 18:97

    Published on:

  15. Content type: Research article

    In 2016, the World Health Organisation set a goal to eliminate viral hepatitis by 2030. Robust epidemiological information underpins all efforts to achieve elimination and this systematic review provides estim...

    Authors: Abby May Falla, Sanne Henrietta Ina Hofstraat, Erika Duffell, Susan Josien Maria Hahné, Lara Tavoschi and Irene Karen Veldhuijzen

    Citation: BMC Infectious Diseases 2018 18:79

    Published on:

  16. Content type: Research article

    Persons with chronic hepatitis B (CHB) infection were reported to suffer severe disease after hepatitis E virus (HEV) superinfection, but the studies regarding HEV seroprevalence in this population were limite...

    Authors: Li Zhang, Zechun Jiang, Jingjing Lv, Jiaye Liu, Bingyu Yan, Yi Feng, Li Li, Guomin Zhang, Fuzhen Wang and Aiqiang Xu

    Citation: BMC Infectious Diseases 2018 18:75

    Published on:

  17. Content type: Case report

    Hepatitis E infection is a global disorder that causes substantial morbidity. Numerous neurologic illnesses, including Guillain–Barre syndrome (GBS), have occurred in patients with hepatitis E virus (HEV) infe...

    Authors: Xiaoqin Zheng, Liang Yu, Qiaomai Xu, Silan Gu and Lingling Tang

    Citation: BMC Infectious Diseases 2018 18:50

    Published on:

  18. Content type: Research article

    Increasing the proportion diagnosed with and on treatment for chronic hepatitis C (CHC) is key to the elimination of hepatitis C in Europe. This study contributes to secondary prevention planning in the Europe...

    Authors: A. M. Falla, A. A. Ahmad, E. Duffell, T. Noori and I. K. Veldhuijzen

    Citation: BMC Infectious Diseases 2018 18:42

    Published on:

  19. Content type: Research article

    Chronic hepatitis B (CHB) related morbidity and mortality can be reduced through risk group screening, linkage to care and anti-viral treatment. This study estimates the number of CHB cases among foreign-born ...

    Authors: Amena A. Ahmad, Abby M. Falla, Erika Duffell, Teymur Noori, Angela Bechini, Ralf Reintjes and Irene K. Veldhuijzen

    Citation: BMC Infectious Diseases 2018 18:34

    Published on:

  20. Content type: Research article

    The overall prevalence of hepatitis B virus (HBV) infection in China is declining. The purpose of this study was to use a community-based epidemiological study to update the infection status of hepatitis B vir...

    Authors: Ping Chen, Qinfen Xie, Ting Chen, Jiawei Wu, Jie Wu, Bing Ruan, Zhiqin Zhang, Hainv Gao and Lanjuan Li

    Citation: BMC Infectious Diseases 2017 17:809

    Published on:

Page 1 of 8

2016 Journal Metrics

Advertisement